Kidney International Reports (Mar 2022)
Retraction notice to “Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.” Kidney Int Rep. 2021;6:613–623
- Robert Provenzano,
- Steven Fishbane,
- Lynda Szczech,
- Robert Leong,
- Khalil G. Saikali,
- Ming Zhong,
- Tyson T. Lee,
- Mark T. Houser,
- Lars Frison,
- John Houghton,
- Dustin J. Little,
- Kin-Hung Peony Yu,
- Thomas B. Neff
Affiliations
- Robert Provenzano
- School of Medicine, Wayne State University, Detroit, Michigan, USA
- Steven Fishbane
- Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA
- Lynda Szczech
- FibroGen, Inc., San Francisco, California, USA
- Robert Leong
- FibroGen, Inc., San Francisco, California, USA
- Khalil G. Saikali
- FibroGen, Inc., San Francisco, California, USA
- Ming Zhong
- FibroGen, Inc., San Francisco, California, USA
- Tyson T. Lee
- FibroGen, Inc., San Francisco, California, USA
- Mark T. Houser
- AstraZeneca, Gaithersburg, Maryland, USA
- Lars Frison
- AstraZeneca, Mölndal, Sweden
- John Houghton
- AstraZeneca, Gaithersburg, Maryland, USA
- Dustin J. Little
- AstraZeneca, Gaithersburg, Maryland, USA
- Kin-Hung Peony Yu
- FibroGen, Inc., San Francisco, California, USA
- Thomas B. Neff
- FibroGen, Inc., San Francisco, California, USA
- Journal volume & issue
-
Vol. 7,
no. 3
p. 665
